• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体-抗生素协同作用:细胞丝状化是噬菌体成功捕食的关键驱动因素。

Phage-antibiotic synergy: Cell filamentation is a key driver of successful phage predation.

机构信息

Laboratoire de Chimie Bactérienne, UMR7283, Centre National de la Recherche Scientifique, Aix-Marseille Université, Marseille, France.

Faculty of Exact and Natural Sciences, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia.

出版信息

PLoS Pathog. 2023 Sep 13;19(9):e1011602. doi: 10.1371/journal.ppat.1011602. eCollection 2023 Sep.

DOI:10.1371/journal.ppat.1011602
PMID:37703280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10519598/
Abstract

Phages are promising tools to fight antibiotic-resistant bacteria, and as for now, phage therapy is essentially performed in combination with antibiotics. Interestingly, combined treatments including phages and a wide range of antibiotics lead to an increased bacterial killing, a phenomenon called phage-antibiotic synergy (PAS), suggesting that antibiotic-induced changes in bacterial physiology alter the dynamics of phage propagation. Using single-phage and single-cell techniques, each step of the lytic cycle of phage HK620 was studied in E. coli cultures treated with either ceftazidime, cephalexin or ciprofloxacin, three filamentation-inducing antibiotics. In the presence of sublethal doses of antibiotics, multiple stress tolerance and DNA repair pathways are triggered following activation of the SOS response. One of the most notable effects is the inhibition of bacterial division. As a result, a significant fraction of cells forms filaments that stop dividing but have higher rates of mutagenesis. Antibiotic-induced filaments become easy targets for phages due to their enlarged surface areas, as demonstrated by fluorescence microscopy and flow cytometry techniques. Adsorption, infection and lysis occur more often in filamentous cells compared to regular-sized bacteria. In addition, the reduction in bacterial numbers caused by impaired cell division may account for the faster elimination of bacteria during PAS. We developed a mathematical model to capture the interaction between sublethal doses of antibiotics and exposition to phages. This model shows that the induction of filamentation by sublethal doses of antibiotics can amplify the replication of phages and therefore yield PAS. We also use this model to study the consequences of PAS on the emergence of antibiotic resistance. A significant percentage of hyper-mutagenic filamentous bacteria are effectively killed by phages due to their increased susceptibility to infection. As a result, the addition of even a very low number of bacteriophages produced a strong reduction of the mutagenesis rate of the entire bacterial population. We confirm this prediction experimentally using reporters for bacterial DNA repair. Our work highlights the multiple benefits associated with the combination of sublethal doses of antibiotics with bacteriophages.

摘要

噬菌体是对抗抗生素耐药细菌的有前途的工具,到目前为止,噬菌体疗法基本上是与抗生素联合进行的。有趣的是,包括噬菌体和广泛的抗生素在内的联合治疗会导致细菌杀伤增加,这种现象称为噬菌体-抗生素协同作用(PAS),这表明抗生素诱导的细菌生理变化改变了噬菌体繁殖的动力学。使用单噬菌体和单细胞技术,在使用头孢他啶、头孢氨苄或环丙沙星(三种诱导丝状化的抗生素)处理的大肠杆菌培养物中研究了噬菌体 HK620 的裂解周期的每个步骤。在亚致死剂量抗生素的存在下,激活 SOS 反应后会触发多种应激耐受和 DNA 修复途径。最显著的影响之一是抑制细菌分裂。结果,由于其表面积增大,大量细胞形成停止分裂但具有更高突变率的丝状体。由于抗生素诱导的丝状体的表面积增大,噬菌体很容易成为这些丝状体的靶标,这通过荧光显微镜和流式细胞术技术得到证实。与正常大小的细菌相比,丝状细胞中的吸附、感染和裂解发生得更频繁。此外,由于细胞分裂受损导致的细菌数量减少可能是 PAS 期间细菌更快消除的原因。我们开发了一个数学模型来捕获亚致死剂量的抗生素和噬菌体暴露之间的相互作用。该模型表明,亚致死剂量的抗生素诱导的丝状化可以放大噬菌体的复制,从而产生 PAS。我们还使用该模型研究 PAS 对抗生素耐药性出现的影响。由于感染的易感性增加,大量超突变丝状细菌有效地被噬菌体杀死。因此,即使添加少量噬菌体也会导致整个细菌群体的突变率大大降低。我们使用细菌 DNA 修复报告基因来实验验证这一预测。我们的工作强调了亚致死剂量抗生素与噬菌体联合使用的多种好处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/8cb5f5a704a1/ppat.1011602.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/1b66af4120e0/ppat.1011602.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/5ecdb1d3b47f/ppat.1011602.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/2112eba3c794/ppat.1011602.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/ec3b8bc5aa8e/ppat.1011602.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/36408f196716/ppat.1011602.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/0e0fd1af5f10/ppat.1011602.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/13f4f8a96a0f/ppat.1011602.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/eb71efdaaaa6/ppat.1011602.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/6b9757b8b351/ppat.1011602.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/6f4496d7fb18/ppat.1011602.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/8cb5f5a704a1/ppat.1011602.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/1b66af4120e0/ppat.1011602.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/5ecdb1d3b47f/ppat.1011602.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/2112eba3c794/ppat.1011602.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/ec3b8bc5aa8e/ppat.1011602.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/36408f196716/ppat.1011602.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/0e0fd1af5f10/ppat.1011602.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/13f4f8a96a0f/ppat.1011602.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/eb71efdaaaa6/ppat.1011602.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/6b9757b8b351/ppat.1011602.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/6f4496d7fb18/ppat.1011602.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aabf/10519598/8cb5f5a704a1/ppat.1011602.g011.jpg

相似文献

1
Phage-antibiotic synergy: Cell filamentation is a key driver of successful phage predation.噬菌体-抗生素协同作用:细胞丝状化是噬菌体成功捕食的关键驱动因素。
PLoS Pathog. 2023 Sep 13;19(9):e1011602. doi: 10.1371/journal.ppat.1011602. eCollection 2023 Sep.
2
Phage-Antibiotic Synergy via Delayed Lysis.噬菌体-抗生素协同作用通过延迟裂解。
Appl Environ Microbiol. 2018 Oct 30;84(22). doi: 10.1128/AEM.02085-18. Print 2018 Nov 15.
3
Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.噬菌体与抗生素单独及联合使用对大肠杆菌的灭活效果。
Virus Res. 2017 Aug 15;240:8-17. doi: 10.1016/j.virusres.2017.07.015. Epub 2017 Jul 23.
4
Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.噬菌体:增强环丙沙星治疗细菌感染疗效的有前途的治疗方法。
J Clin Lab Anal. 2023 May;37(9-10):e24932. doi: 10.1002/jcla.24932. Epub 2023 Jun 28.
5
Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny.在不同抗生素类别中观察到温和噬菌体-抗生素协同作用,揭示了预防溶原性的新机制。
mBio. 2024 Jun 12;15(6):e0050424. doi: 10.1128/mbio.00504-24. Epub 2024 May 17.
6
Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth.噬菌体-抗生素协同作用(PAS):β-内酰胺类和喹诺酮类抗生素刺激毒性噬菌体的生长。
PLoS One. 2007 Aug 29;2(8):e799. doi: 10.1371/journal.pone.0000799.
7
Temperate phage-antibiotic synergy eradicates bacteria through depletion of lysogens.温和噬菌体-抗生素协同作用通过耗尽溶原菌来清除细菌。
Cell Rep. 2021 May 25;35(8):109172. doi: 10.1016/j.celrep.2021.109172.
8
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.噬菌体-抗生素协同作用是由独特的抗菌作用机制和化学计量比组合驱动的。
mBio. 2020 Aug 4;11(4):e01462-20. doi: 10.1128/mBio.01462-20.
9
Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.洋葱伯克霍尔德菌复合体的噬菌体 - 抗生素协同作用(PAS):抗生素刺激溶菌噬菌体活性。
Appl Environ Microbiol. 2015 Feb;81(3):1132-8. doi: 10.1128/AEM.02850-14. Epub 2014 Dec 1.
10
Aminoglycosides Antagonize Bacteriophage Proliferation, Attenuating Phage Suppression of Bacterial Growth, Biofilm Formation, and Antibiotic Resistance.氨基糖苷类抗生素拮抗噬菌体增殖,减弱噬菌体对细菌生长、生物膜形成和抗生素耐药性的抑制作用。
Appl Environ Microbiol. 2021 Jul 13;87(15):e0046821. doi: 10.1128/AEM.00468-21.

引用本文的文献

1
Evaluating phage lytic activity: from plaque assays to single-cell technologies.评估噬菌体裂解活性:从噬菌斑测定到单细胞技术。
Front Microbiol. 2025 Aug 29;16:1659093. doi: 10.3389/fmicb.2025.1659093. eCollection 2025.
2
Bacteriophage-Based Approach Against Biofilm Infections Associated with Medical Devices: A Narrative Review of ESKAPE Pathogens.基于噬菌体的医疗器械相关生物膜感染防治方法:对ESKAPE病原体的叙述性综述
Int J Mol Sci. 2025 Sep 6;26(17):8699. doi: 10.3390/ijms26178699.
3
Phage provoke growth delays and SOS response induction despite CRISPR-Cas protection.

本文引用的文献

1
Benefits of Combined Phage-Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review.联合噬菌体-抗生素疗法控制耐药菌的益处:文献综述
Antibiotics (Basel). 2022 Jun 22;11(7):839. doi: 10.3390/antibiotics11070839.
2
Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study.噬菌体-抗生素联合治疗在一项临床前研究中对鲍曼不动杆菌具有优越的治疗效果。
EBioMedicine. 2022 Jun;80:104045. doi: 10.1016/j.ebiom.2022.104045. Epub 2022 May 7.
3
Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
尽管有CRISPR-Cas保护,噬菌体仍会引发生长延迟和SOS反应诱导。
Philos Trans R Soc Lond B Biol Sci. 2025 Sep 4;380(1934):20240474. doi: 10.1098/rstb.2024.0474.
4
Current Trends in Approaches to Prevent and Control Antimicrobial Resistance in Aquatic Veterinary Medicine.水生兽医学中预防和控制抗菌药物耐药性方法的当前趋势
Pathogens. 2025 Jul 10;14(7):681. doi: 10.3390/pathogens14070681.
5
Phage-Antibiotic Combinations for Pseudomonas: Successes in the Clinic and In Vitro Tenuously Connected.用于治疗假单胞菌的噬菌体-抗生素组合:临床与体外研究成果的微弱关联
Microb Biotechnol. 2025 Jul;18(7):e70193. doi: 10.1111/1751-7915.70193.
6
Antagonistic effect of kanamycin on kanamycin-resistant Escherichia coli infection by BtuB-targeting bacteriophages.卡那霉素对靶向BtuB的噬菌体感染耐卡那霉素大肠杆菌的拮抗作用。
Arch Virol. 2025 Jul 3;170(8):172. doi: 10.1007/s00705-025-06358-7.
7
Isolation and identification of a newly discovered broad-spectrum Acinetobacter baumannii phage and therapeutic validation against pan-resistant Acinetobacter baumannii.一种新发现的广谱鲍曼不动杆菌噬菌体的分离鉴定及其对泛耐药鲍曼不动杆菌的治疗验证
Virol Sin. 2025 Jun 27. doi: 10.1016/j.virs.2025.06.003.
8
The Current Landscape of Phage-Antibiotic Synergistic (PAS) Interactions.噬菌体 - 抗生素协同(PAS)相互作用的当前态势
Antibiotics (Basel). 2025 May 27;14(6):545. doi: 10.3390/antibiotics14060545.
9
A bacteriophage-conditional mouse model reveals the impact of phages within a conventionally colonized gut microbiota.一种噬菌体条件性小鼠模型揭示了噬菌体在传统定殖的肠道微生物群中的影响。
Cell Host Microbe. 2025 May 14;33(5):745-758.e6. doi: 10.1016/j.chom.2025.04.002. Epub 2025 Apr 28.
10
Extreme diversity of phage amplification rates and phage-antibiotic interactions revealed by PHORCE.PHORCE揭示的噬菌体扩增速率和噬菌体-抗生素相互作用的极端多样性。
PLoS Biol. 2025 Apr 8;23(4):e3003065. doi: 10.1371/journal.pbio.3003065. eCollection 2025 Apr.
临床实践中噬菌体与抗生素的相互作用:迄今我们所了解的情况。
J Biomed Sci. 2022 Mar 30;29(1):23. doi: 10.1186/s12929-022-00806-1.
4
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
5
Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.噬菌体治疗和噬菌体衍生蛋白在骨和关节感染患者中的过去和未来。
Viruses. 2021 Dec 2;13(12):2414. doi: 10.3390/v13122414.
6
Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?21世纪的噬菌体疗法:是否有噬菌体介导疗效的现代临床证据?
Pharmaceuticals (Basel). 2021 Nov 13;14(11):1157. doi: 10.3390/ph14111157.
7
Misic, a general deep learning-based method for the high-throughput cell segmentation of complex bacterial communities.米西奇,一种基于广义深度学习的高通量复杂细菌群落细胞分割方法。
Elife. 2021 Sep 9;10:e65151. doi: 10.7554/eLife.65151.
8
Temperate phage-antibiotic synergy eradicates bacteria through depletion of lysogens.温和噬菌体-抗生素协同作用通过耗尽溶原菌来清除细菌。
Cell Rep. 2021 May 25;35(8):109172. doi: 10.1016/j.celrep.2021.109172.
9
Novel Virulent Bacteriophages Infecting Mediterranean Isolates of the Plant Pest and .新型烈性噬菌体感染地中海地区的植物害虫 和 。
Viruses. 2021 Apr 21;13(5):725. doi: 10.3390/v13050725.
10
Synergistic Killing and Re-Sensitization of to Antibiotics by Phage-Antibiotic Combination Treatment.噬菌体-抗生素联合治疗对细菌的协同杀伤作用及使其重新敏感化
Pharmaceuticals (Basel). 2021 Feb 25;14(3):184. doi: 10.3390/ph14030184.